Sign in

CIK 0001867096 · Large accelerated filer

Xeris Biopharma Holdings, Inc.

Sign in to watch
Ticker
XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
871082097
Phone
844-445-5704
Business address
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
  1. 4 Planned sale See Remarks sold 25,000 shares at $12.49 ($312,215)
  2. 4 Planned sale See Remarks sold 5,000 shares at $10.23 ($51,174)
  3. 4 Planned sale See Remarks sold 25,000 shares at $10.23 ($255,828)
  4. 4 Planned sale See Remarks sold 15,000 shares at $10.23 ($153,488)
  5. 4 Grant or award Director acquired 22,365 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale See Remarks sold 5,000 shares at $9.41 ($47,037)
  8. 4 Planned sale See Remarks sold 15,000 shares at $9.41 ($141,120)
  9. 4 Planned sale See Remarks sold 16,666 shares at $9.41 ($156,792)
  10. 4 Planned sale See Remarks sold 25,000 shares at $10.00 ($250,000)
  11. 4 Planned sale See Remarks sold 15,000 shares at $8.49 ($127,308)
  12. 4 Planned sale See Remarks sold 16,666 shares at $8.49 ($141,434)
  13. 4 Planned sale See Remarks sold 5,000 shares at $8.50 ($42,500)
  14. 4 Shares withheld for taxes See Remarks gave up 36,645 shares (to pay taxes)
  15. 4 Shares withheld for taxes See Remarks gave up 21,918 shares (to pay taxes)
  16. 4 Planned sale See Remarks sold 5,000 shares at $8.50 ($42,500)
  17. 4 Planned sale See Remarks sold 15,000 shares at $8.02 ($120,240)
  18. 4 Planned sale See Remarks sold 16,666 shares at $8.01 ($133,553)
  19. 4 Planned sale See Remarks sold 45,000 shares at an average $8.52 ($383,176)
  20. 4 Grant or award Director acquired 33,582 shares (grant or award)

Page 1 of 9 · 178 filings